Detalhe da pesquisa
1.
Autogenous Control of 5'TOP mRNA Stability by 40S Ribosomes.
Mol Cell
; 67(1): 55-70.e4, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28673543
2.
Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage.
EMBO J
; 39(13): e103838, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484960
3.
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
Blood
; 137(24): 3351-3364, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512431
4.
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.
Acta Neuropathol
; 138(6): 1053-1074, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428936
5.
Lysosomal degradation ensures accurate chromosomal segregation to prevent chromosomal instability.
Autophagy
; 17(3): 796-813, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573315
6.
The 40S-LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity.
Sci Adv
; 7(48): eabg9275, 2021 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818049
7.
Phosphofructokinases Axis Controls Glucose-Dependent mTORC1 Activation Driven by E2F1.
iScience
; 20: 434-448, 2019 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31627130
8.
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
Nat Commun
; 10(1): 3979, 2019 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484926
9.
Ribosome biogenesis in cancer: new players and therapeutic avenues.
Nat Rev Cancer
; 18(1): 51-63, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192214
10.
Corrigendum: Ribosome biogenesis in cancer: new players and therapeutic avenues.
Nat Rev Cancer
; 18(2): 134, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368746
11.
Erratum for Brahimi-Horn et al., "Local Mitochondrial-Endolysosomal Microfusion Cleaves the Voltage-Dependent Anion Channel 1 To Promote Survival in Hypoxia".
Mol Cell Biol
; 42(1): e0051521, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35049340
12.
AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts.
Oncotarget
; 6(14): 11833-47, 2015 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059436
13.
Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation.
Cancer Metab
; 3: 8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26322231
14.
Local mitochondrial-endolysosomal microfusion cleaves voltage-dependent anion channel 1 to promote survival in hypoxia.
Mol Cell Biol
; 35(9): 1491-505, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25691661
15.
Biochemical titration of glycogen in vitro.
J Vis Exp
; (81): e50465, 2013 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24300406
16.
Glycogen Synthesis is Induced in Hypoxia by the Hypoxia-Inducible Factor and Promotes Cancer Cell Survival.
Front Oncol
; 2: 18, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22649778
17.
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition
Artigo
em Inglês
| ARCA | ID: arc-37085